Rita Sobral

Rita focuses on cross-border M&A transactions and other complex corporate matters. She advises public and private companies across numerous industries, including technology, life sciences, consumer goods and financial services. She is fluent in English, Portuguese and Spanish and proficient in German.

Rita’s representative M&A transactions include:

Technology

• Keyrock’s acquisition of assets from Blockfills
• Axur Holding’s agreement to sell to Infoblox
• Megaport’s acquisition of Latitude.sh
• PlayAI’s sale to Meta
• Feedzai’s acquisition of Demyst
• IQM’s de-SPAC combination with Real Asset Acquisition Corp. for approximately $1.8 billion
• Kpler’s acquisition of Spire Maritime for $241 million

Healthcare and life sciences

• Ambros Therapeutics’ reverse merger with Werewolf Therapeutics
• Scancell Holdings’ reverse merger agreement with Neuphoria Therapeutics
• Orphai Therapeutics’ reverse merger with Quince Therapeutics
• 908 Devices’ acquisition of NIRLAB
• Kezar Life Sciences’ sale to Aurinia Pharmaceuticals
• Candid Therapeutics’ reverse merger with Rallybio
• Swiss Rockets’ acquisition of Complete Genomics
• Oxford Biomedica’s acquisition of assets from Resilience
• Araris Biotech’s sale to Taiho Pharmaceutical for up to $1.14 billion
• Lava Therapeutics’ sale to Xoma
• Kheiron Medical Technologies’ sale to RadNet
• VectivBio’s sale to Ironwood for a $1 billion cash offer
• Repare Therapeutics’ sale to XenoTherapeutics

Other

• Brown Advisory’s acquisition of The Rock Creek Group
• AECOM’s acquisition of Consigli